logo
  

EARNINGS SUMMARY: Details of Alnylam Pharmaceuticals Inc. Q4 Earnings Report

Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

-Earnings: -$90.72 million in Q4 vs. -$21.39 million in the same period last year.
-EPS: -$1.07 in Q4 vs. -$0.28 in the same period last year.
-Analysts projected -$0.96 per share
-Revenue: $7.55 million in Q4 vs. $24.02 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT